Aier Eye Hospital Group (SHE:300015) — Market Cap & Net Worth
Market Cap & Net Worth: Aier Eye Hospital Group (300015)
Aier Eye Hospital Group (SHE:300015) has a market capitalization of $10.90 Billion (CN¥74.51 Billion) as of September 16, 2026. Listed on the SHE stock exchange, this China-based company holds position #2100 globally and #209 in its home market, demonstrating a -3.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aier Eye Hospital Group's stock price CN¥7.99 by its total outstanding shares 9325396670 (9.33 Billion). Also see 300015 total assets for a full breakdown of the balance sheet.
Aier Eye Hospital Group Market Cap History: 2015 to 2026
Aier Eye Hospital Group's market capitalization history from 2015 to 2026. Data shows growth from $4.92 Billion to $10.90 Billion (7.84% CAGR). Also see Aier Eye Hospital Group operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Aier Eye Hospital Group is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$1.14 Trillion | 0.95% | #19 of 100 |
Weight: Aier Eye Hospital Group's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aier Eye Hospital Group Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aier Eye Hospital Group's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Aier Eye Hospital Group share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.67x
Aier Eye Hospital Group's market cap is 0.67 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.62x
Aier Eye Hospital Group's market cap is 4.62 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $4.70 Billion | $4.00 Billion | $556.99 Million | 1.17x | 8.43x |
| 2017 | $7.29 Billion | $5.96 Billion | $742.51 Million | 1.22x | 9.82x |
| 2018 | $9.40 Billion | $8.01 Billion | $1.01 Billion | 1.17x | 9.32x |
| 2019 | $18.48 Billion | $9.99 Billion | $1.38 Billion | 1.85x | 13.40x |
| 2020 | $45.62 Billion | $11.91 Billion | $1.72 Billion | 3.83x | 26.46x |
| 2021 | $33.45 Billion | $15.00 Billion | $2.32 Billion | 2.23x | 14.40x |
| 2022 | $32.05 Billion | $16.11 Billion | $2.52 Billion | 1.99x | 12.70x |
| 2023 | $21.32 Billion | $20.37 Billion | $3.36 Billion | 1.05x | 6.35x |
| 2024 | $18.08 Billion | $20.98 Billion | $3.56 Billion | 0.86x | 5.08x |
| 2025 | $14.98 Billion | $22.35 Billion | $3.24 Billion | 0.67x | 4.62x |
Competitor Companies of 300015 by Market Capitalization
Companies near Aier Eye Hospital Group in the global market cap rankings as of September 16, 2026. Review Aier Eye Hospital Group tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Aier Eye Hospital Group by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #911 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1001 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1234 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $423.82 |
| #911 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.39 |
| #1001 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1234 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.85 |
Aier Eye Hospital Group Historical Marketcap From 2015 to 2026
Between 2015 and today, Aier Eye Hospital Group's market cap moved from $4.92 Billion to $ 10.90 Billion, with a yearly change of 7.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥10.90 Billion | -27.23% |
| 2025 | CN¥14.98 Billion | -17.13% |
| 2024 | CN¥18.08 Billion | -15.20% |
| 2023 | CN¥21.32 Billion | -33.47% |
| 2022 | CN¥32.05 Billion | -4.18% |
| 2021 | CN¥33.45 Billion | -26.67% |
| 2020 | CN¥45.62 Billion | +146.85% |
| 2019 | CN¥18.48 Billion | +96.60% |
| 2018 | CN¥9.40 Billion | +28.86% |
| 2017 | CN¥7.29 Billion | +55.36% |
| 2016 | CN¥4.70 Billion | -4.56% |
| 2015 | CN¥4.92 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Aier Eye Hospital Group was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.90 Billion USD |
| MoneyControl | $10.90 Billion USD |
| MarketWatch | $10.90 Billion USD |
| marketcap.company | $10.90 Billion USD |
| Reuters | $10.90 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aier Eye Hospital Group
Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, Europe, and Southeast Asia. It offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and lens fitting for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and p… Read more